The study is to be published on-line in Nature on December 25. One of Canada’s pre-eminent researchers of autoimmune disease, Dr. Kathy Siminovitch, played a leading role in the study.
Rheumatoid arthritis is a leading cause of disability world-wide, afflicting up to one in a hundred individuals, according to World Health Organization estimates. About half of adults with the autoimmune disease are unable to work full time within 10 years of diagnosis. The findings of this study by an international consortium of researchers, including Dr. Siminovitch, offer new potential targets for therapy. She is the Director of the Office of Personalized Genomics and Innovative Medicine at Mount Sinai Hospital and a Senior Investigator at the hospital’s Lunenfeld-Tanenbaum Research Institute in Toronto, Canada.
Read more at: MedicalXpress